Marksans Pharma sets Aug 20, 2026 as record date for ₹0.90 dividend

Marksans Pharma Ltd has announced that the Board of Directors, in a meeting held on July 3, 2026, has fixed August 20, 2026, as the record date for determining shareholder eligibility for the final dividend for the financial year ended March 31, 2026. The recommended final dividend is ₹0.90 per equity share. The 34th Annual General Meeting (AGM) will be held on August 27, 2026, where shareholders will vote on this dividend. If approved, the dividend payment is expected on or after September 10, 2026, subject to tax deductions.